StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.07−0.32 (-0.93%)

Close on Nov 18, 2026Market cap $2.25BP/E 6.3Yield –

Lakefront Biotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lakefront Biotherapeutics's pe ratio was 6.1× on Nov 11, 2026, against 24.1× a year earlier. Over the last 5 years it ranged from 4.9× to 83.4×, with a median of 24.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.1×−18.7
2025Dec 31, 202524.9×+16.6
2024Dec 31, 20248.3×−19.2
2021Feb 26, 202127.4×−5.1
2020Dec 31, 202032.5×−42.4
2018Feb 28, 201874.9×+6.4
2017Dec 29, 201768.4×–

More Lakefront Biotherapeutics figures

See a number that looks wrong?